Skip to main content
Erschienen in: Annals of Nuclear Medicine 6/2019

25.03.2019 | Original Article

Preliminary clinical assessment of dynamic 18F-fluorodeoxyglucose positron emission tomography/computed tomography for evaluating lymph node metastasis in patients with lung cancer: a prospective study

verfasst von: Takayoshi Shinya, Yoichi Otomi, Michiko Kubo, Mitsuhiro Kinoshita, Katsuya Takechi, Naoto Uyama, Moriaki Yamanaka, Kaori Terazawa, Hiroaki Toba, Yoshimi Bando, Hideki Otsuka, Masafumi Harada

Erschienen in: Annals of Nuclear Medicine | Ausgabe 6/2019

Einloggen, um Zugang zu erhalten

Abstract

Objective

We assessed the diagnostic capacity of dynamic fluorine-18-fluorodeoxyglucose positron emission tomography/computed tomography (18F-FDG PET/CT) and dual-time-point (DTP) PET/CT to explore the optimal scan timing for nodal staging in lung cancer.

Methods

Thirty-four patients with lung cancer underwent dynamic and consecutive DTP PET/CT scans. Two readers visually evaluated FDG uptake within each lymph node (LN) and pulmonary artery (metastatic LN: n = 10; nonmetastatic LN: n = 121). For each dynamic and DTP scan, we compared the maximum standardized uptake value (SUVmax) and the retention index of the SUVmax (RI-SUVmax) between metastatic and nonmetastatic LNs. We compared the diagnostic capacity of the dynamic and DTP scans using receiver operating characteristic (ROC) analyses.

Results

In the visual analyses of LN metastases, a sensitivity of 20.0–60.0% and specificity of 97.5–100.0% were identified for the first to third dynamic scans. The sensitivity of the 1-h early and 2-h delayed scans was 80.0% and 90.0%, respectively, whereas the specificity was 66.9% and 47.9%, respectively. The visual analysis of the dynamic second phase had the highest accuracy. Semiquantitative analyses revealed that the SUVmax was significantly higher for metastatic LNs than for nonmetastatic LNs in the dynamic second and third phases and the 1-h early and 2-h delayed phases (p < 0.05 for all). The RI-SUVmax was higher in metastatic LNs than in nonmetastatic LNs for the dynamic scan (p = 0.004) and the DTP scan (p = 0.002). The ROC analyses showed that SUV2 and SUV3 had higher performances with high specificity, high negative predictive value, and high accuracy than the other parameters. The area under the ROC curve of the RI-SUV-dual-time-point had the highest value (0.794) without any significant differences between the area under the ROC curves for all parameters (p > 0.05 for all).

Conclusions

Based on the visual and semiquantitative analyses, 18F-FDG dynamic PET/CT exhibited excellent performance with extremely high specificity in the dynamic second phase.
Literatur
2.
Zurück zum Zitat Zhao L, He ZY, Zhong XN, Cui ML. (18)FDG-PET/CT for detection of mediastinal nodal metastasis in non-small cell lung cancer: a meta-analysis. Surg Oncol. 2012;21:230–6.CrossRefPubMed Zhao L, He ZY, Zhong XN, Cui ML. (18)FDG-PET/CT for detection of mediastinal nodal metastasis in non-small cell lung cancer: a meta-analysis. Surg Oncol. 2012;21:230–6.CrossRefPubMed
3.
Zurück zum Zitat Shinya T, Rai K, Okumura Y, Fujiwara K, Matsuo K, Yonei T, et al. Dual-time-point F-18 FDG PET/CT for evaluation of intrathoracic lymph nodes in patients with non-small cell lung cancer. Clin Nucl Med. 2009;34:216–21.CrossRefPubMed Shinya T, Rai K, Okumura Y, Fujiwara K, Matsuo K, Yonei T, et al. Dual-time-point F-18 FDG PET/CT for evaluation of intrathoracic lymph nodes in patients with non-small cell lung cancer. Clin Nucl Med. 2009;34:216–21.CrossRefPubMed
4.
Zurück zum Zitat Nishiyama Y, Yamamoto Y, Kimura N, Ishikawa S, Sasakawa Y, Ohkawa M. Dual-time-point FDG-PET for evaluation of lymph node metastasis in patients with non-small-cell lung cancer. Ann Nucl Med. 2008;22:245–50.CrossRefPubMed Nishiyama Y, Yamamoto Y, Kimura N, Ishikawa S, Sasakawa Y, Ohkawa M. Dual-time-point FDG-PET for evaluation of lymph node metastasis in patients with non-small-cell lung cancer. Ann Nucl Med. 2008;22:245–50.CrossRefPubMed
5.
Zurück zum Zitat Matthies A, Hickeson M, Cuchiara A, Alavi A. Dual time point 18F-FDG PET for the evaluation of pulmonary nodules. J Nucl Med. 2002;43:871–5.PubMed Matthies A, Hickeson M, Cuchiara A, Alavi A. Dual time point 18F-FDG PET for the evaluation of pulmonary nodules. J Nucl Med. 2002;43:871–5.PubMed
6.
Zurück zum Zitat Demura Y, Tsuchida T, Ishizaki T, Mizuno S, Totani Y, Ameshima S, et al. 18F-FDG accumulation with PET for differentiation between benign and malignant lesions in the thorax. J Nucl Med. 2003;44:540–8.PubMed Demura Y, Tsuchida T, Ishizaki T, Mizuno S, Totani Y, Ameshima S, et al. 18F-FDG accumulation with PET for differentiation between benign and malignant lesions in the thorax. J Nucl Med. 2003;44:540–8.PubMed
7.
Zurück zum Zitat Prenzel KL, Mönig SP, Sinning JM, Baldus SE, Brochhagen HG, Schneider PM, et al. Lymph node size and metastatic infiltration in non-small cell lung cancer. Chest. 2003;123:463–7.CrossRefPubMed Prenzel KL, Mönig SP, Sinning JM, Baldus SE, Brochhagen HG, Schneider PM, et al. Lymph node size and metastatic infiltration in non-small cell lung cancer. Chest. 2003;123:463–7.CrossRefPubMed
8.
Zurück zum Zitat Yen RF, Chen KC, Lee JM, Chang YC, Wang J, Cheng MF, et al. 18F-FDG PET for the lymph node staging of non-small cell lung cancer in a tuberculosis-endemic country: is dual time point imaging worth the effort? Eur J Nucl Med Mol Imaging. 2008;35:1305–15.CrossRefPubMed Yen RF, Chen KC, Lee JM, Chang YC, Wang J, Cheng MF, et al. 18F-FDG PET for the lymph node staging of non-small cell lung cancer in a tuberculosis-endemic country: is dual time point imaging worth the effort? Eur J Nucl Med Mol Imaging. 2008;35:1305–15.CrossRefPubMed
9.
Zurück zum Zitat Kim YK, Lee KS, Kim BT, Choi JY, Kim H, Kwon OJ, et al. Mediastinal nodal staging of nonsmall cell lung cancer using integrated 18F-FDG PET/CT in a tuberculosis-endemic country: diagnostic efficacy in 674 patients. Cancer. 2007;109:1068–77.CrossRefPubMed Kim YK, Lee KS, Kim BT, Choi JY, Kim H, Kwon OJ, et al. Mediastinal nodal staging of nonsmall cell lung cancer using integrated 18F-FDG PET/CT in a tuberculosis-endemic country: diagnostic efficacy in 674 patients. Cancer. 2007;109:1068–77.CrossRefPubMed
10.
Zurück zum Zitat Schierz JH, Opfermann T, Steenbeck J, Lopatta E, Settmacher U, Stallmach A, et al. Early dynamic 18F-FDG PET to detect hyperperfusion in hepatocellular carcinoma liver lesions. J Nucl Med. 2013;54:848–54.CrossRefPubMed Schierz JH, Opfermann T, Steenbeck J, Lopatta E, Settmacher U, Stallmach A, et al. Early dynamic 18F-FDG PET to detect hyperperfusion in hepatocellular carcinoma liver lesions. J Nucl Med. 2013;54:848–54.CrossRefPubMed
11.
Zurück zum Zitat Bernstine H, Braun M, Yefremov N, Lamash Y, Carmi R, Stern D, et al. FDG PET/CT early dynamic blood flow and late standardized uptake value determination in hepatocellular carcinoma. Radiology. 2011;260:503–10.CrossRefPubMed Bernstine H, Braun M, Yefremov N, Lamash Y, Carmi R, Stern D, et al. FDG PET/CT early dynamic blood flow and late standardized uptake value determination in hepatocellular carcinoma. Radiology. 2011;260:503–10.CrossRefPubMed
12.
Zurück zum Zitat Epelbaum R, Frenkel A, Haddad R, Sikorski N, Strauss LG, Israel O, et al. Tumour aggressiveness and patient outcome in cancer of the pancreas assessed by dynamic 18F-FDG PET/CT. J Nucl Med. 2013;54:12–8.CrossRefPubMed Epelbaum R, Frenkel A, Haddad R, Sikorski N, Strauss LG, Israel O, et al. Tumour aggressiveness and patient outcome in cancer of the pancreas assessed by dynamic 18F-FDG PET/CT. J Nucl Med. 2013;54:12–8.CrossRefPubMed
13.
Zurück zum Zitat Belakhlef S, Church C, Jani C, Lakhanpl S. Early dynamic PET/CT and 18F-FDG blood flow imaging in bladder cancer detection: a novel approach. Clin Nucl Med. 2012;37:366–8.CrossRefPubMed Belakhlef S, Church C, Jani C, Lakhanpl S. Early dynamic PET/CT and 18F-FDG blood flow imaging in bladder cancer detection: a novel approach. Clin Nucl Med. 2012;37:366–8.CrossRefPubMed
14.
Zurück zum Zitat Nakajima R, Abe K, Kondo T, Tanabe K, Sakai S. Clinical role of early dynamic FDG-PET/CT for the evaluation of renal cell carcinoma. Eur Radiol. 2016;26(6):1852–62.CrossRefPubMed Nakajima R, Abe K, Kondo T, Tanabe K, Sakai S. Clinical role of early dynamic FDG-PET/CT for the evaluation of renal cell carcinoma. Eur Radiol. 2016;26(6):1852–62.CrossRefPubMed
16.
Zurück zum Zitat Brierley JD, Mary K, Gospodarowicz C, Wittekind, editors. UICC TNM Classification of Malignant Tumours. 8th ed. Hoboken: Wiley-Blackwell; 2016. Brierley JD, Mary K, Gospodarowicz C, Wittekind, editors. UICC TNM Classification of Malignant Tumours. 8th ed. Hoboken: Wiley-Blackwell; 2016.
19.
Zurück zum Zitat Kanda Y. Investigation of the freely available easy-to-use software ‘EZR’ for medical statistics. Bone Marrow Transplant. 2013;48:452–8.CrossRefPubMed Kanda Y. Investigation of the freely available easy-to-use software ‘EZR’ for medical statistics. Bone Marrow Transplant. 2013;48:452–8.CrossRefPubMed
20.
Zurück zum Zitat Gupta N, Gill H, Graeber G, Bishop H, Hurst J, Stephens T. Dynamic positron emission tomography with F-18 fluorodeoxyglucose imaging in differentiation of benign from malignant lung/mediastinal lesions. Chest. 1998;114:1105–11.CrossRefPubMed Gupta N, Gill H, Graeber G, Bishop H, Hurst J, Stephens T. Dynamic positron emission tomography with F-18 fluorodeoxyglucose imaging in differentiation of benign from malignant lung/mediastinal lesions. Chest. 1998;114:1105–11.CrossRefPubMed
22.
Zurück zum Zitat Huang YE, Lu HI, Liu FY, Huang YJ, Lin MC, Chen CF, et al. Solitary pulmonary nodules differentiated by dynamic F-18 FDG PET in a region with high prevalence of granulomatous disease. J Radiat Res. 2012;53:306–12. Epub 2012 Feb 25.CrossRefPubMed Huang YE, Lu HI, Liu FY, Huang YJ, Lin MC, Chen CF, et al. Solitary pulmonary nodules differentiated by dynamic F-18 FDG PET in a region with high prevalence of granulomatous disease. J Radiat Res. 2012;53:306–12. Epub 2012 Feb 25.CrossRefPubMed
23.
Zurück zum Zitat Kwon SY, Min JJ, Song HC, Choi C, Na KJ, Bom HS. Impact of lymphoid follicles and histiocytes on the false-positive FDG uptake of lymph nodes in non-small cell lung cancer. Nucl Med Mol Imaging. 2011;45:185–91.CrossRefPubMedPubMedCentral Kwon SY, Min JJ, Song HC, Choi C, Na KJ, Bom HS. Impact of lymphoid follicles and histiocytes on the false-positive FDG uptake of lymph nodes in non-small cell lung cancer. Nucl Med Mol Imaging. 2011;45:185–91.CrossRefPubMedPubMedCentral
Metadaten
Titel
Preliminary clinical assessment of dynamic 18F-fluorodeoxyglucose positron emission tomography/computed tomography for evaluating lymph node metastasis in patients with lung cancer: a prospective study
verfasst von
Takayoshi Shinya
Yoichi Otomi
Michiko Kubo
Mitsuhiro Kinoshita
Katsuya Takechi
Naoto Uyama
Moriaki Yamanaka
Kaori Terazawa
Hiroaki Toba
Yoshimi Bando
Hideki Otsuka
Masafumi Harada
Publikationsdatum
25.03.2019
Verlag
Springer Singapore
Erschienen in
Annals of Nuclear Medicine / Ausgabe 6/2019
Print ISSN: 0914-7187
Elektronische ISSN: 1864-6433
DOI
https://doi.org/10.1007/s12149-019-01350-z

Weitere Artikel der Ausgabe 6/2019

Annals of Nuclear Medicine 6/2019 Zur Ausgabe